RAMM Pharma Corp Valuation
| RAMMFDelisted Stock | USD 0.06 0.00 0.00% |
RAMM Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of RAMM Pharma Corp from evaluating the entity fundamentals such as return on asset of -0.0789, and Shares Outstanding of 122.4 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that RAMM Pharma's price fluctuation is very steady at this time. Calculation of the real value of RAMM Pharma Corp is based on 3 months time horizon. Increasing RAMM Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the RAMM pink sheet is determined by what a typical buyer is willing to pay for full or partial control of RAMM Pharma Corp. Since RAMM Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of RAMM Pink Sheet. However, RAMM Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.055 | Real 0.0468 | Hype 0.055 | Naive 0.055 |
The real value of RAMM Pink Sheet, also known as its intrinsic value, is the underlying worth of RAMM Pharma Corp Company, which is reflected in its stock price. It is based on RAMM Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of RAMM Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of RAMM Pharma Corp helps investors to forecast how RAMM pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of RAMM Pharma more accurately as focusing exclusively on RAMM Pharma's fundamentals will not take into account other important factors: RAMM Pharma Total Value Analysis
RAMM Pharma Corp is at this time expected to have takeover price of 1.85 M with market capitalization of 15.16 M, debt of 8.69 K, and cash on hands of 12.79 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the RAMM Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.85 M | 15.16 M | 8.69 K | 12.79 M |
RAMM Pharma Investor Information
About 35.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.18. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. RAMM Pharma Corp recorded a loss per share of 0.05. The entity had not issued any dividends in recent years. Based on the key measurements obtained from RAMM Pharma's financial statements, RAMM Pharma Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.RAMM Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. RAMM Pharma has an asset utilization ratio of 6.89 percent. This implies that the Company is making $0.0689 for each dollar of assets. An increasing asset utilization means that RAMM Pharma Corp is more efficient with each dollar of assets it utilizes for everyday operations.RAMM Pharma Ownership Allocation
RAMM Pharma owns a total of 122.4 Million outstanding shares. RAMM Pharma Corp has substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the entity is less than the current market value, you may not be able to make money on it.RAMM Pharma Profitability Analysis
The company reported the revenue of 4.12 M. Net Loss for the year was (7.11 M) with loss before overhead, payroll, taxes, and interest of (37.32 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates RAMM Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in RAMM Pharma and how it compares across the competition.
About RAMM Pharma Valuation
The pink sheet valuation mechanism determines RAMM Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of RAMM Pharma. We calculate exposure to RAMM Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of RAMM Pharma's related companies.RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada. Ramm Pharma is traded on OTC Exchange in the United States.
8 Steps to conduct RAMM Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates RAMM Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct RAMM Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain RAMM Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine RAMM Pharma's revenue streams: Identify RAMM Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research RAMM Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish RAMM Pharma's growth potential: Evaluate RAMM Pharma's management, business model, and growth potential.
- Determine RAMM Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate RAMM Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
RAMM Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as RAMM Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 123.4 M | |
| Retained Earnings | -22.4 M | |
| Shares Float | 89.2 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |